跳至主要内容
临床试验/NCT07012616
NCT07012616已完成不适用

Supraclavicular Brachial Plexus Block as Opioid Sparing Technique in Pediatrics Undergoing Arteriovenous Fistula Creation: A Randomized Controlled Trial

Tanta University1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2025年6月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
1
主要终点
Intraoperative fentanyl consumption

研究概览

简要总结

This study aims to evaluate the efficacy of supraclavicular brachial plexus block as an opioid-sparing technique in pediatric patients undergoing arteriovenous fistula creation.

详细描述

The global incidence of end-stage renal failure (ESRF) is increasing. The preferred procedure for patients with ESRF undergoing maintenance Haemodialysis (HD) is the placement of an arteriovenous fistula (AVF).

In patients with ESRF, brachial plexus block (BPB) is frequently employed to administer anesthesia for the establishment or modification of AVF. This technique offers pain relief, sympathetic blockade, ideal surgical conditions, and a sufficient duration of postoperative block, preventing arterial spasms and graft thrombosis

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
6 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Age from 6 to 18 years.
  • Both sexes.
  • American Society of Anesthesiology (ASA) physical status I- III.
  • Undergoing arteriovenous fistula creation under general anesthesia.

排除标准

  • Allergy to local anesthetics.
  • Infection at the site of block.
  • Local infection.
  • Coagulation disorder.
  • Previously failed or revision of blocked arteriovenous fistula.

研究组 & 干预措施

Supraclavicular brachial plexus block group

Experimental

Patients will receive an ultrasound-guided supraclavicular brachial plexus block.

干预措施: Supraclavicular brachial plexus block (Other)

Control group

No Intervention

Patients will not receive supraclavicular brachial plexus block as a control group.

结局指标

主要结局

Intraoperative fentanyl consumption

时间窗: Intraoperatively

次要结局

  • Total opioid consumption(24 hours postoperatively)
  • Time to the 1st rescue analgesia(24 hours postoperatively)
  • Degree of pain(24 hours postoperatively)
  • Patient satisfaction(24 hours postoperatively)
  • Incidence of adverse events(24 hours postoperatively)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohammed Said ElSharkawy

Lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt

Tanta University

研究点 (1)

Loading locations...

相似试验